Orasure Tech Inc (OSUR) 7.78 $OSUR Medical Instruments &

New Post Public Reply Private Reply Replies (0) Message Board

Jun 11, 2016 at 10:03 AM

Orasure Tech Inc (OSUR) 7.78 $OSUR

Medical Instruments & Supplies Equities Roundup -- Endologix, Becton Dickinson, Waters, and OraSure Technologies
PR Newswire - Thu Jun 09, 7:25AM CDT
On Wednesday, June 08, 2016, the NASDAQ Composite ended the trading session at 4,974.64, up 0.26%; the Dow Jones Industrial Average advanced 0.37% to finish at 18,005.05; and the S&P 500 closed at 2,119.12, up 0.33%. The gains were broad based as all the sectors ended the session in positive. ActiveWallSt.com has initiated coverage on the following equities: Endologix Inc. (NASDAQ: ELGX), Becton, Dickinson and Company (NYSE: BDX), Waters Corporation (NYSE: WAT), and OraSure Technologies Inc. (NASDAQ: OSUR). Learn more about these stocks by accessing their free trade alerts at:
BDX: 169.29 (-0.94), ELGX: 12.68 (-0.03), WAT: 138.04 (-2.01), OSUR: 7.78 (-0.13)

Uptrend Call Working As OraSure Technologies Stock Rises 21.3% (OSUR)
Comtex SmarTrend(R) - Tue Jun 07, 1:29AM CDT
SmarTrend identified an Uptrend for OraSure Technologies (NASDAQ:OSUR) on February 10th, 2016 at $6.52. In approximately 4 months, OraSure Technologies has returned 21.26% as of today's recent price of $7.90.
OSUR: 7.78 (-0.13)

OraSure Technologies to Present at the Jefferies 2016 Healthcare Conference
GlobeNewswire - Tue May 31, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Jefferies 2016 Healthcare Conference in New York. The conference will be simultaneously webcast over the Internet.
OSUR: 7.78 (-0.13)

Looking for a Growth Stock? Why It is Time to Focus on OraSure Technologies (OSUR)
Zacks Equity Research - Zacks Investment Research - Tue May 24, 8:48AM CDT
OraSure Technologies (OSUR) is seeing solid earnings estimate revision activity, and is a great company from a Zacks Growth perspective.
OSUR: 7.78 (-0.13)

Boston Scientific (BSX): Q1 Earnings Beat amid CRM Woes
Zacks Equity Research - Zacks Investment Research - Thu May 12, 7:18AM CDT
On May 11, 2016, we issued an updated research report on leading medical devices company, Boston Scientific Corporation (BSX). The stock currently carries a Zacks Rank #2 (Buy).
BSX: 23.02 (-0.30), LMAT: 15.03 (-0.06), NUVA: 58.98 (-1.03), OSUR: 7.78 (-0.13)

OraSure Technologies to Hold Virtual Annual Meeting of Stockholders
GlobeNewswire - Tue May 10, 5:44AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), announced that its 2016 Annual Meeting of Stockholders will be a completely virtual meeting, conducted as a live webcast beginning at 10:00 a.m. Eastern Time (7:00 a.m. Pacific Time) on Tuesday, May 17, 2016.
OSUR: 7.78 (-0.13)

OraSure Announces 2016 First Quarter Financial Results
GlobeNewswire - Wed May 04, 3:00PM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the first quarter ended March 31, 2016.
OSUR: 7.78 (-0.13)

OraSure Technologies to Present at the UBS 2016 Global Healthcare Conference
GlobeNewswire - Tue May 03, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the UBS 2016 Global Healthcare Conference in New York. The conference will be simultaneously webcast over the Internet.
OSUR: 7.78 (-0.13)

OraSure Technologies Appoints New Chief Science Officer
GlobeNewswire - Fri Apr 15, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) announced today that Michael Reed, Ph.D. has been named as the Company's Senior Vice President of Research and Development and Chief Science Officer. He will begin working at the Company on April 18, 2016.
OSUR: 7.78 (-0.13)

OraSure Technologies Earnings Conference Call Invitation
GlobeNewswire - Wed Apr 13, 5:00AM CDT
OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 first quarter financial results, 2016 second quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, May 4, 2016.
OSUR: 7.78 (-0.13)

CVS Health Strong on Omnicare Buyout, Integration Prospects
Zacks Equity Research - Zacks Investment Research - Tue Apr 12, 1:40PM CDT
On Apr 12, 2016, we issued an updated research report on Rhode Island-based pharmacy retail giant CVS Health Corp. (CVS).
BAX: 44.49 (-0.26), RMD: 59.80 (-0.70), CVS: 96.67 (-0.32), OSUR: 7.78 (-0.13)

C.R. Bard at 52-Week High, Product Suite Holds the Key
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 11:40AM CDT
Shares of C.R. Bard Inc (BCR) rallied to a new 52-week high of $205.52 on Apr 1, eventually closing a tad bit lower at $204.69.
BCR: 225.37 (-1.15), ALGN: 78.83 (-0.86), BAX: 44.49 (-0.26), OSUR: 7.78 (-0.13)

Thermo Fisher Steals Affymetrix Deal, Expands Antibody Line
Zacks Equity Research - Zacks Investment Research - Mon Apr 04, 10:10AM CDT
With the closure of the Affymetrix deal, Thermo Fisher(TMO) expects to enjoy an extended antibody portfolio, which will boost the company's leadership in biosciences.
TMO: 151.80 (-2.35), BAX: 44.49 (-0.26), OFIX: 46.16 (-1.09), OSUR: 7.78 (-0.13)

Medtronic Unveils NURO System in US for Overactive Bladder
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:30PM CDT
We believe this product launch will allow Medtronic (MDT) to overcome the issues it has been facing in its Neuromodulation business division over the past couple of quarters
MDT: 85.70 (-0.08), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)

Mead Johnson Launches Enfinitas Product Line in China
Zacks Equity Research - Zacks Investment Research - Thu Mar 31, 12:25PM CDT
Mead Johnson Nutrition Company (MJN) recently launched its Enfinitas premium-priced product line in China.
MJN: 83.79 (-0.38), BAX: 44.49 (-0.26), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)

Quest Diagnostics Grows Through Organic, Inorganic Means
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 3:05PM CDT
On Mar 30, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
BAX: 44.49 (-0.26), DGX: 77.45 (-1.30), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)

Cepheid Up on International Launch of Next-Gen MRSA Test
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 2:50PM CDT
Cepheid's (CPHD) Xpert MRSA NxG assay is a next-generation version of the market-leading molecular diagnostic test for Methicillin-Resistant Staphyloccus aureus (MRSA).
CPHD: 28.27 (-0.60), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)

Stryker (SYK) Scales a 52-Week High: Right Time to Buy?
Zacks Equity Research - Zacks Investment Research - Wed Mar 30, 11:40AM CDT
Shares of Stryker Corp (SYK) rallied to a new 52-week high of $106.92 on Mar 29, eventually closing a tad bit lower at $106.87.
BAX: 44.49 (-0.26), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13), SYK: 114.56 (-0.77)

Cardiovascular Systems: Market Dynamics, Margins Strong
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:45PM CDT
Currently, Cardiovascular Systems (CSII) stands to gain from several favorable trends existing in the PAD as well CAD market spaces
CSII: 18.36 (+0.41), OFIX: 46.16 (-1.09), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)

Thermo Fisher to Acquire Affymetrix, Origin's Bid Falls Flat
Zacks Equity Research - Zacks Investment Research - Tue Mar 29, 1:40PM CDT
On completion, the Thermo Fisher(TMO)-Affymetrix (AFFX) deal is expected to generate attractive financial returns
TMO: 151.80 (-2.35), AFFX: 14.01 (+0.02), HRC: 50.10 (-1.12), OSUR: 7.78 (-0.13)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Classet and Reelist Revamp Frontline Hiring Methods

Social Media's New Role in Hiring Who'd have thought? Scrolling through cat videos now lands you a job interview. The partnership between Classet and Reelist has thrown the hiring game a curveball, offering a seamless ride from a hashtagged post to a phone chat with an AI recruiter named Joy—and all in record time. For those looking to hire frontline or skilled trades...

San Ysidro Urgent Care Addresses Care Desert in San Diego

A Long Overdue Remedy in San Diego Healthcare access shouldn't be a roll of the dice based on where you live, but for too many folks in Southeastern San Diego, that’s been the sad reality. Today, though, there's a new twist in the tale. Blue Shield of California Promise Health Plan just dropped a hefty $1 million into an urgent care facility that’s more than bricks...

Brennan Takes a Swing: Barrasso Endorsement in Hand

Brennan Shakes Up Wyoming Politics You don’t need a crystal ball to see the chess game unfolding in Wyoming's political landscape. Shannon Brennan's bid for the House seat in Teton County's District 23 got a heavy artillery boost today. She’s landed the endorsement of Senator John Barrasso, none other than the Senate Majority Whip and a formidable player in the Senate...

Lear Capital Hits $5 Billion Milestone: Trust or Hype?

A Golden Milestone or Just Glitter? Lear Capital's announcement of surpassing $5 billion in precious metals transactions feels like one of those moments where you tilt your head and ask, "Is it really what it seems?" With nearly 150,000 customers and almost three decades of hustling in the glittering world of gold and silver, they've certainly carved out a name in the...

Evaluating PT and OT Benefits: What’s Driving Outcomes?

Shifting Gears: Rethinking PT and OT Benefits With an uptick in conversations around physical therapy (PT) and occupational therapy (OT) benefits, it's time for health plans and employers to step up their game. Let's face it: we're not just treating aches and pains anymore. We're dealing with the big picture here - helping folks get back to their daily grind effectively...

Canton Fair 2026: Tech and Tradition Transform Jewelry

Tech-Savvy Elegance at Canton Fair Dive into the glitz and glamour of the jewelry zone at the 140th Canton Fair, where technology and craftsmanship are forging a new narrative for luxury accessories. This isn’t just your grandmother’s jewelry box we're talking about anymore. We’re witnessing the dawn of precious metal smart rings and dual-band smart watches that...

Tifosi Pizza Debuts Italian Flair at Irvine's Centerview

Pizza with a Punch: Irvine's Tifosi Heats Up We've got another chef-driven concept cooking up in Irvine. This time, it's Tifosi Pizza + Trattoria stirring the pot at Centerview. The spot's bringing 'New, New York' style pizza, blending Big Apple boldness with Italian tradition, and tossing in a bit of California flair for good measure. "The main idea is to create...

Mission Bancorp Hits Record Earnings, Extends Buyback

Record-Breaking Quarter Amid Challenging Times When Mission Bancorp's earnings hit the tape today, the numbers were enough to catch anyone's eye—$9.2 million in net income for Q3 2026, a 6% increase from last year. That's not small potatoes, especially considering the economic fog we're navigating through. AJ Antongiovanni, holding the reins as CEO, credits the bank's...

Global Movement Countdown Begins with The Power Hour™

Imagine a world where everyone stands up and moves for sixty minutes. That's the idea behind The Power Hour™, a bold initiative launched straight from TikTok Headquarters in New York City. On October 26, 2026, this ambitious global movement embarked on a 365-day countdown to a world-record attempt in October 2027. The mission? To transform movement into widespread...

Gentex Faces Investigation as Shares Tumble 7%

Investigating Gentex's Financial Setback Gentex Corporation, ticker NASDAQ:GNTX, is caught in a bit of a blizzard right now. Their shares took a nosedive, down 7%, after some messy numbers came out in their third-quarter report—tariffs and the kind of pricing pressure that makes grown investors wince. If you threw your chips in on Gentex and got burned, the lawyers are...